Implementation of AZD7442 (Tixagevimab/Cilgavimab) COVID-19 Pre-exposure Prophylaxis (PrEP) in the Largest Health Maintenance Organization in Israel: Real-world Uptake and Sociodemographic and Clinical Characteristics Across Immunocompromised Patient Groups

Samah Hayek,Joseph Levy,Galit Shaham,Noa Dagan, Danielle Serby, Hadar Duskin-Bitan, Adva Yarden,Cátia Ferreira, Idit Livnat, Sabada Dube, Sylvia Taylor, Sudhir Venkatesan,Ran D. Balicer,Doron Netzer,Alon Peretz

Infectious Diseases and Therapy(2024)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要